Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,612 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06296472Recruiting
Comparing hand therapy for De Quervain's disease after steroid injection
This trial compares two types of hand therapy for patients with De Quervain's disease, a painful condition affecting the thumb tendons. One group receives standard hand therapy, while the other gets a new approach after an ultrasound-guided steroid injection.
BolognaAges 18 years+ - NCT06305611Recruiting
Studying Kawasaki disease in Europe and North India
This study looks at children with Kawasaki disease, a condition that causes inflammation in blood vessels. The goal is to learn more about how it affects kids in Europe and North India.
Rio de JaneiroAges 1–17 - NCT06309017Recruiting
Nutrition before bowel surgery for IBD patients
This trial tests whether a special nutrition drink taken before surgery can help people with inflammatory bowel disease (IBD) recover better after bowel surgery. It is for adults with IBD who are already scheduled for surgery at NYU Langone Health.
New York, New YorkAges 18 years+ - NCT06315933Recruiting
Anesthesia and brain development in children with congenital scoliosis
This study looks at how anesthesia (medicine used to put children to sleep during surgery) may affect the brain development of children with congenital scoliosis. It will help doctors understand how to make anesthesia safer for children with this condition.
Beijing, Beijing MunicipalityAges 6–16 - NCT06308562Recruiting
Fuzzy sock after leg amputation to help healing
This trial tests a fuzzy compression sock worn on the leg after amputation below the knee (transtibial amputation). The goal is to see if it helps the wound heal better in people with peripheral artery disease.
Rochester, MinnesotaAges 18 years+ - NCT06295614Recruiting
ARC-IM therapy for walking problems in Parkinson's
This study tests a new therapy called ARC-IM to help with walking issues like freezing or balance problems in people with Parkinson's. It aims to see if the therapy is safe and can improve movement.
Lausanne, Canton of VaudAges 18 years+ - NCT06313944Recruiting
German registry of Alzheimer's treated with sound wave therapy
This trial is a registry that collects information about people with Alzheimer's disease who receive a treatment called transcranial pulse stimulation (TPS), which uses gentle sound waves to stimulate the brain. The goal is to track safety and how well it works over time.
Potsdam, BrandenburgAges 18–85 - NCT06305624Recruiting
Smartphone app to help people with alcohol-related liver disease stop drinking
This trial tests whether a smartphone program can help people with alcohol-related liver disease reduce or stop drinking. If you have liver disease related to alcohol and have used alcohol in the past 6 months, this app-based support may be for you.
Lansing, MichiganAges 18 years+ - NCT06294691RecruitingPhase 3
Timing of stem cell infusion to prevent GVHD in blood cancer
This study is testing whether the timing of a stem cell infusion affects the chance of developing graft-versus-host disease (aGVHD), a common complication after transplant. It may help make transplants safer for people with blood cancers.
Hefei, AnhuiAges 12–60 - NCT06283966RecruitingPhase 3
Triple inhaler for COPD with heart risk
This study tests a triple-combination inhaler (budesonide, glycopyrronium, and formoterol) to see if it can help protect the heart and lungs in people with COPD who also have heart problems or high risk for them.
Athens, AlabamaAges 40–80 - NCT06294613Recruiting
Robotic eye surgery for vitreoretinal conditions
This study tests a robotic system to assist eye surgery for certain retina and vitreous conditions, such as bleeding in the eye or a wrinkle on the macula. It aims to see if the robot can safely help improve vision.
Ghent, East FlandersAges 18–85 - NCT06293924Enrolling by invitation
Testing fluid around the heart in recurring pericarditis
This study analyzes pericardial fluid (the fluid around your heart) to understand why pericarditis comes back. If you have pericarditis or other heart fluid buildup requiring drainage, or if you're having heart surgery, you may be able to participate.
Milan, LombardyAges 18 years+ - NCT06291571Enrolling by invitation
Gut bacteria and body response in liver disease
This study looks at the bacteria in your gut (microbiome) and how your body responds to liver disease. Researchers want to learn if these factors can help improve care for people with liver problems.
AberdeenAges 18–70 - NCT06291116RecruitingPhase 2
Safety of rotigotine patch for ADPKD patients
This study tests a skin patch called rotigotine to see if it is safe for people with ADPKD. It may help with blood pressure control, but you cannot have advanced kidney failure or certain other health issues.
AmiensAges 18–60 - NCT06281665RecruitingPhase 4
Aspirin after preeclampsia: the TAP trial
This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06294028Recruiting
Ablation vs Defibrillator for Well-Tolerated Fast Heartbeat
This study compares two treatments for a fast heartbeat called ventricular tachycardia in people with prior heart attacks and relatively preserved heart function: one uses heat energy (ablation) to fix the electrical problem, and the other places an implantable defibrillator that shocks the heart to restore normal rhythm. The goal is to find which approach works better for people whose symptoms are well-tolerated.
Toulouse, FranceAges 18–90 - NCT06275477Recruiting
Gallium-68 FAPI-46 PET/CT for inflammation and fibrosis
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
BrestAges 18 years+ - NCT06286748Recruiting
Beetroot drink and exercise for kidney disease
This study tests if drinking beetroot extract along with a structured exercise program can help people with chronic kidney disease. It looks at whether this combination can improve health and delay the need for more advanced treatments.
Rio de Janeiro, Rio de JaneiroAges 18–65 - NCT06285279RecruitingPhase 1
CAR-T cell therapy for hard-to-treat autoimmune kidney diseases
This trial tests a new type of cell therapy called CAR-T cells that target two proteins (BCMA and CD19) to treat autoimmune kidney diseases that are not responding to standard treatments. The goal is to see if this therapy can help control the disease and improve kidney function.
Nanjing, JiangsuAges 18–65 - NCT06255886RecruitingPhase 4
Treatment for acid reflux in babies under 1 year
This trial tests a treatment for babies under 1 year old who have frequent and troublesome reflux (GERD). It aims to find a safe and effective way to reduce symptoms like crying, feeding problems, and breathing pauses.
Aabenraa, Region SyddanmarkAges 1 month–1 year - NCT06267859Enrolling by invitationEarly Phase 1
Better treatment for common childhood illnesses
This study aims to improve treatment for children with common illnesses like bronchitis and for those who get sick often, to help them recover faster and stay healthier.
Tashkent, Yunus-obad DistrictAges 3 days–15 years - NCT06266663Recruiting
IBD study on social factors, medications, and quality of life
This study looks at how social and economic factors (like where you live and your access to care) affect medication use and quality of life for people with inflammatory bowel disease. By completing an online survey, you can help researchers understand these connections better.
New York, New YorkAges 18 years+ - NCT06274528RecruitingPhase 2
DORA and lemborexant in Alzheimer's biomarkers study
This study is testing whether a sleep medication called lemborexant can improve sleep and reduce Alzheimer's-related proteins in healthy older adults with no memory problems. It could help find new ways to delay or prevent Alzheimer's disease.
St Louis, MissouriAges 65 years+ - NCT06260891RecruitingPhase 2
Zinc study for sickle cell disease and bone health
This study tests if taking zinc supplements can improve bone health in people with sickle cell disease. It's for those with certain types of sickle cell disease (SS or S-Beta zero thalassemia) who are not on chronic transfusions or zinc supplements.
Oakland, CaliforniaAges 15–40
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,612 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.